BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warner JJ, Crook HL, Whelan KM, Bleser WK, Roiland RA, Hamilton Lopez M, Saunders RS, Wang TY, Hernandez AF, Mcclellan MB, Califf RM, Brown N; the American Heart Association Partnering with Regulators Learning Collaborative*. Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative’s Partnering With Regulators Learning Collaborative. Circ: Cardiovascular Quality and Outcomes 2020;13. [DOI: 10.1161/circoutcomes.120.006606] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Soltani Hekmat A, Farjam M, Javanmardi K, Behrouz S, Zarenezhad E, Soltani Rad MN. Design, Synthesis and In Vivo Cardiovascular Evaluation of Some Novel Aryloxy Propanol Amino Acid Derivatives. ChemistrySelect 2021;6:13595-600. [DOI: 10.1002/slct.202101920] [Reference Citation Analysis]
2 Jandhyala R. The effect of adding real-world evidence to regulatory submissions on the breadth of population indicated for rare disease medicine treatment by the European Medicines Agency. J Pharm Policy Pract 2022;15:36. [PMID: 35509059 DOI: 10.1186/s40545-022-00433-z] [Reference Citation Analysis]
3 Balla S, Gomez SE, Rodriguez F. Disparities in Cardiovascular Care and Outcomes for Women From Racial/Ethnic Minority Backgrounds. Curr Treat Options Cardiovasc Med 2020;22:75. [PMID: 33223802 DOI: 10.1007/s11936-020-00869-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]